https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Open-source, fully-automated hybrid cardiac substructure segmentation: development and optimisation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53327 Wed 28 Feb 2024 16:29:04 AEDT ]]> The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19936 Wed 27 Jul 2022 14:01:52 AEST ]]> Analysis of cardiac substructure dose in a large, multi-centre danish breast cancer cohort (the DBCG HYPO trial): Trends and predictive modelling https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43546 Wed 21 Sep 2022 16:26:10 AEST ]]> International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40147 in situ (DCIS) of the breast. Materials and methods: Baseline and 3-year cosmesis were assessed using the European Organization for Research and Treatment of Cancer (EORTC) Cosmetic Rating System and digital images in a randomised trial of non-low risk DCIS treated with postoperative WBI +/− TBB. Baseline cosmesis was assessed for four geographic clusters of treating centres. Cosmetic failure was a global score of fair or poor. Cosmetic deterioration was a score change from excellent or good at baseline to fair or poor at three years. Odds ratios for cosmetic deterioration by WBI dose-fractionation and TBB use were calculated for both scoring systems. Results: 1608 women were enrolled from 11 countries between 2007 and 2014. 85–90% had excellent or good baseline cosmesis independent of geography or assessment method. TBB (16 Gy in 8 fractions) was associated with a >2-fold risk of cosmetic deterioration (p < 0.001). Hypofractionated WBI (42.5 Gy in 16 fractions) achieved statistically similar 3-year cosmesis compared to conventional WBI (50 Gy in 25 fractions) (p ≥ 0.18). The adverse impact of a TBB was not significantly associated with WBI fractionation (interaction p ≥ 0.30). Conclusions: Cosmetic failure from BCS was similar across international jurisdictions. A TBB of 16 Gy increased the rate of cosmetic deterioration. Hypofractionated WBI achieved similar 3-year cosmesis as conventional WBI in women treated with BCS for DCIS.]]> Thu 11 Aug 2022 14:56:25 AEST ]]> Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: results from two large cancer facilities https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28322 Sat 24 Mar 2018 07:25:14 AEDT ]]> Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52865 Mon 30 Oct 2023 10:01:47 AEDT ]]> The effect of imaging modality (magnetic resonance imaging vs. computed tomography) and patient position (supine vs. prone) on target and organ at risk doses in partial breast irradiation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49529 Mon 22 May 2023 08:31:17 AEST ]]>